BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25376584)

  • 1. Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population.
    Ou CY; Chen CZ; Hsiue TR; Lin SH; Wang JY
    Respirology; 2015 Feb; 20(2):296-303. PubMed ID: 25376584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of surfactant protein D rs2243639, Interleukin (IL)-1β rs16944 and IL-1RN rs2234663 in chronic obstructive pulmonary disease, healthy smokers, and non-smokers.
    Issac MS; Ashur W; Mousa H
    Mol Diagn Ther; 2014 Jun; 18(3):343-54. PubMed ID: 24504887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation.
    Obeidat M; Li X; Burgess S; Zhou G; Fishbane N; Hansel NN; Bossé Y; Joubert P; Hao K; Nickle DC; van den Berge M; Timens W; Cho MH; Hobbs BD; de Jong K; Boezen M; Hung RJ; Rafaels N; Mathias R; Ruczinski I; Beaty TH; Barnes KC; Paré PD; Sin DD;
    Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29191953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.
    Foreman MG; Kong X; DeMeo DL; Pillai SG; Hersh CP; Bakke P; Gulsvik A; Lomas DA; Litonjua AA; Shapiro SD; Tal-Singer R; Silverman EK
    Am J Respir Cell Mol Biol; 2011 Mar; 44(3):316-22. PubMed ID: 20448057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.
    Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM
    Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between ADRB2 Genetic Polymorphisms and the Risk of Chronic Obstructive Pulmonary Disease: A Case-Control Study in a Chinese Population.
    Zhao H; Wu X; Dong CL; Wang BY; Zhao J; Cao XE
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):491-496. PubMed ID: 28753063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Variants in IL6R and ADAM19 are Associated with COPD Severity in a Mexican Mestizo Population.
    Pérez-Rubio G; Silva-Zolezzi I; Fernández-López JC; Camarena Á; Velázquez-Uncal M; Morales-Mandujano F; Hernández-Zenteno Rde J; Flores-Trujillo F; Sánchez-Romero C; Velázquez-Montero A; Espinosa de Los Monteros C; Sansores RH; Ramírez-Venegas A; Falfán-Valencia R
    COPD; 2016 Oct; 13(5):610-5. PubMed ID: 27078193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.
    Bowler RP
    COPD; 2012 Dec; 9(6):651-3. PubMed ID: 23244171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant protein D multimerization and gene polymorphism in COPD and asthma.
    Fakih D; Akiki Z; Junker K; Medlej-Hashim M; Waked M; Salameh P; Holmskov U; Bouharoun-Tayoun H; Chamat S; Sorensen GL; Jounblat R
    Respirology; 2018 Mar; 23(3):298-305. PubMed ID: 28960651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SP-D polymorphisms and the risk of COPD.
    Shakoori TA; Sin DD; Bokhari SN; Ghafoor F; Shakoori AR
    Dis Markers; 2012; 33(2):91-100. PubMed ID: 22846212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genetic polymorphisms with chronic obstructive pulmonary disease in the Hainan population: a case-control study.
    Ding Y; Yang D; Xun X; Wang Z; Sun P; Xu D; He P; Niu H; Jin T
    Int J Chron Obstruct Pulmon Dis; 2015; 10():7-13. PubMed ID: 25565795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD.
    Duvoix A; Miranda E; Perez J; Sorensen GL; Holmskov U; Trapnell BC; Madsen J; Clark HW; Edwards LD; Miller BE; Tal-Singer RM; Lomas DA
    COPD; 2011 Apr; 8(2):79-95. PubMed ID: 21495836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of surfactant protein D in emphysema revealed by genetic association study.
    Ishii T; Hagiwara K; Kamio K; Ikeda S; Arai T; Mieno MN; Kumasaka T; Muramatsu M; Sawabe M; Gemma A; Kida K
    Eur J Hum Genet; 2012 Feb; 20(2):230-5. PubMed ID: 21934714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants in multiple genes polymorphism association analysis of COPD in the Chinese Li population.
    Ding Y; Yang D; Zhou L; Xu J; Chen Y; He P; Yao J; Chen J; Niu H; Sun P; Jin T
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1455-63. PubMed ID: 26251585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease.
    Kim DK; Cho MH; Hersh CP; Lomas DA; Miller BE; Kong X; Bakke P; Gulsvik A; Agustí A; Wouters E; Celli B; Coxson H; Vestbo J; MacNee W; Yates JC; Rennard S; Litonjua A; Qiu W; Beaty TH; Crapo JD; Riley JH; Tal-Singer R; Silverman EK;
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1238-47. PubMed ID: 23144326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced.
    Heidinger K; König IR; Bohnert A; Kleinsteiber A; Hilgendorff A; Gortner L; Ziegler A; Chakraborty T; Bein G
    Immunogenetics; 2005 Apr; 57(1-2):1-7. PubMed ID: 15700120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
    Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
    Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant protein D is a candidate biomarker for subclinical tobacco smoke-induced lung damage.
    Johansson SL; Tan Q; Holst R; Christiansen L; Hansen NC; Hojland AT; Wulf-Johansson H; Schlosser A; Titlestad IL; Vestbo J; Holmskov U; Kyvik KO; Sorensen GL
    Am J Physiol Lung Cell Mol Physiol; 2014 May; 306(9):L887-95. PubMed ID: 24610936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGLN2 and RNF150 genetic variants are associated with chronic obstructive pulmonary disease risk in the Chinese population.
    Ding Y; Niu H; Yang H; Sun P; Chen Y; Duan M; Xu D; Xu J; Jin T
    Int J Chron Obstruct Pulmon Dis; 2015; 10():145-51. PubMed ID: 25609945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of HHIP polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population.
    Wang B; Zhou H; Yang J; Xiao J; Liang B; Li D; Zhou H; Zeng Q; Fang C; Rao Z; Yu H; Ou X; Feng Y
    Gene; 2013 Nov; 531(1):101-5. PubMed ID: 23994291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.